← Back to Cognitive Deep Dive

P21

CNTF-derived peptide fragment — neurogenesis promoter

Protocol Summary

Route
SubQ
Dose Range
1–2 mg/day
Cycling
30 days on, variable off period
Evidence Tier
animal

Primary Benefits

Safety Profile

Limited data. Generally well-tolerated in animal studies. No human clinical trials.

Research Findings

No findings yet. The weekly research pipeline will populate this section.